Ovarian Cancer Biomarker Profile (Prognostic Note)
This test measures specific biomarkers to help assess the risk or progression of ovarian cancer. It may be used in conjunction with other diagnostic tests for monitoring treatment response or guiding further care.
["Biomarkers help track ovarian cancer activity but are not a standalone diagnosis."]
Key facts at a glance
- LOINC
- 68564-4
- Short code
- OBGYN Prog note
- Synonyms
- OBGYN Prog note
- Category
- chemistry
- Sample
- serum
- Container
- Red-top tube (SST)
- Units
- N/A
- Fasting
- false
- Population
- adult
- Sex
- all
- Age range
- 18–65 years
- Method
- obstetrics-and-gynecology
- Specimen volume
- 5 mL
- Stability
- Room temperature: 4h, Refrigerated: 24h, Frozen: 7d
- Hemolysis max
- 500
- Lipemia max
- 1000
- Icterus max
- 500
- TAT
- 4–24 hours
- Order
- routine
What This Test Measures
The test evaluates multiple biomarkers, including potential tumor markers and molecular indicators, which may reflect ovarian cancer presence or behavior. Results are interpreted in the context of clinical findings, patient history, and other diagnostic tests.
Why It Might Be Ordered
Your healthcare provider may order this test if you have ovarian cancer, are at high risk for it, or are undergoing treatment to monitor progression or response. It may also be used in screening or follow-up for certain ovarian conditions.
How the Test Works
Blood samples are collected and analyzed using advanced immunoassay methods to detect and quantify specific biomarkers. These biomarkers may include substances released by ovarian tumors or associated with cancer activity.
What to Expect Before the Test
No special preparation is typically needed. You may have a small needle inserted into a vein (usually in your arm) to draw blood. This is usually quick and done in a clinic or lab setting.
Clinical interpretation
How abnormal results are interpreted and what conditions they suggest.
Clinical Significance
Short name
Ovarian Cancer Biomarker Panel
Frequently asked questions
Biomarkers can provide insights into cancer activity but are not definitive on their own. Elevated levels may suggest tumor presence or progression, while stable or declining levels could indicate treatment response. Results are always reviewed by a healthcare provider in the full clinical picture.
How often will I need this test?
Will the results show if I have ovarian cancer?
Sources
- 1
- 2Lab Tests OnlineSource
- 3
Click any link to access the full source. PubMed Central (PMC) links provide free full-text access.
This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 16, 2026. · Read our editorial policy